Skip to main content
SpringerLink
Log in

Blood Pressure in Thyroid Dysfunction

  • Chapter
  • First Online:
Thyroid and Heart

  • 448 Accesses

Abstract

The prevalence of elevated blood pressure is rapidly increasing worldwide due to an ageing population, lifestyle changes and urbanisation. The National Health and Nutrition Examination Survey estimates that 31% of all adults were suffering from elevated blood pressure in the United States in 1999–2000 [1]. On average, every 4 years, 19% of people with elevated BP progresses to clinical hypertension which contributes to the burden of heart disease, stroke and kidney failure and premature mortality and disability [2]. The identification and subsequent address of potential risk factors are essential steps in the prevention and control of elevated blood pressure.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch Intern Med. 2004;164(19):2126–34.

    Article  PubMed  Google Scholar 

  2. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet. 2001;358(9294):1682–6.

    Article  CAS  PubMed  Google Scholar 

  3. Jabbar A, Pingitore A, Pearce SH, Zaman A, Iervasi G, Razvi S. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol. 2017;14(1):39–55.

    Article  CAS  PubMed  Google Scholar 

  4. Hiroi Y, Kim HH, Ying H, Furuya F, Huang Z, Simoncini T, et al. Rapid nongenomic actions of thyroid hormone. Proc Natl Acad Sci U S A. 2006;103(38):14104–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Danzi S, Klein I. Thyroid hormone and blood pressure regulation. Curr Hypertens Rep. 2003;5(6):513–20.

    Article  PubMed  Google Scholar 

  6. Bahouth SW, Cui X, Beauchamp MJ, Park EA. Thyroid hormone induces beta1-adrenergic receptor gene transcription through a direct repeat separated by five nucleotides. J Mol Cell Cardiol. 1997;29(12):3223–37.

    Article  CAS  PubMed  Google Scholar 

  7. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344(7):501–9.

    Article  CAS  PubMed  Google Scholar 

  8. Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116(15):1725–35.

    Article  PubMed  Google Scholar 

  9. Ching GW, Franklyn JA, Stallard TJ, Daykin J, Sheppard MC, Gammage MD. Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis. Heart. 1996;75(4):363–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Iglesias P, Acosta M, Sanchez R, Fernandez-Reyes MJ, Mon C, Diez JJ. Ambulatory blood pressure monitoring in patients with hyperthyroidism before and after control of thyroid function. Clin Endocrinol. 2005;63(1):66–72.

    Article  CAS  Google Scholar 

  11. Saito I, Saruta T. Hypertension in thyroid disorders. Endocrinol Metab Clin N Am. 1994;23(2):379–86.

    Article  CAS  Google Scholar 

  12. Osman F, Franklyn JA, Holder RL, Sheppard MC, Gammage MD. Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy: a matched case-control study. J Am Coll Cardiol. 2007;49(1):71–81.

    Article  CAS  PubMed  Google Scholar 

  13. Volzke H, Ittermann T, Schmidt CO, Dorr M, John U, Wallaschofski H, et al. Subclinical hyperthyroidism and blood pressure in a population-based prospective cohort study. Eur J Endocrinol. 2009;161(4):615–21.

    Article  PubMed  CAS  Google Scholar 

  14. Cai Y, Ren Y, Shi J. Blood pressure levels in patients with subclinical thyroid dysfunction: a meta-analysis of cross-sectional data. Hypertens Res. 2011;34(10):1098–105.

    Article  PubMed  Google Scholar 

  15. Volzke H, Alte D, Dorr M, Wallaschofski H, John U, Felix SB, et al. The association between subclinical hyperthyroidism and blood pressure in a population-based study. J Hypertens. 2006;24(10):1947–53.

    Article  PubMed  CAS  Google Scholar 

  16. Walsh JP, Bremner AP, Bulsara MK, O’Leary P, Leedman PJ, Feddema P, et al. Subclinical thyroid dysfunction and blood pressure: a community-based study. Clin Endocrinol. 2006;65(4):486–91.

    Article  CAS  Google Scholar 

  17. Walsh JP, Bremner AP, Bulsara MK, O'Leary P, Leedman PJ, Feddema P, et al. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med. 2005;165(21):2467–72.

    Article  PubMed  Google Scholar 

  18. Kaminski G, Makowski K, Michalkiewicz D, Kowal J, Ruchala M, Szczepanek E, et al. The influence of subclinical hyperthyroidism on blood pressure, heart rate variability, and prevalence of arrhythmias. Thyroid. 2012;22(5):454–60.

    Article  CAS  PubMed  Google Scholar 

  19. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008;29(1):76–131.

    Article  CAS  PubMed  Google Scholar 

  20. Duan Y, Peng W, Wang X, Tang W, Liu X, Xu S, et al. Community-based study of the association of subclinical thyroid dysfunction with blood pressure. Endocrine. 2009;35(2):136–42.

    Article  CAS  PubMed  Google Scholar 

  21. Liu D, Jiang F, Shan Z, Wang B, Wang J, Lai Y, et al. A cross-sectional survey of relationship between serum TSH level and blood pressure. J Hum Hypertens. 2010;24(2):134–8.

    Article  CAS  PubMed  Google Scholar 

  22. Luboshitzky R, Aviv A, Herer P, Lavie L. Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid. 2002;12(5):421–5.

    Article  PubMed  Google Scholar 

  23. Fommei E, Iervasi G. The role of thyroid hormone in blood pressure homeostasis: evidence from short-term hypothyroidism in humans. J Clin Endocrinol Metab. 2002;87(5):1996–2000.

    Article  CAS  PubMed  Google Scholar 

  24. Dart AM, Lacombe F, Yeoh JK, Cameron JD, Jennings GL, Laufer E, et al. Aortic distensibility in patients with isolated hypercholesterolaemia, coronary artery disease, or cardiac transplant. Lancet. 1991;338(8762):270–3.

    Article  CAS  PubMed  Google Scholar 

  25. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37(5):1236–41.

    Article  CAS  PubMed  Google Scholar 

  26. Dernellis J, Panaretou M. Effects of thyroid replacement therapy on arterial blood pressure in patients with hypertension and hypothyroidism. Am Heart J. 2002;143(4):718–24.

    Article  CAS  PubMed  Google Scholar 

  27. Obuobie K, Smith J, Evans LM, John R, Davies JS, Lazarus JH. Increased central arterial stiffness in hypothyroidism. J Clin Endocrinol Metab. 2002;87(10):4662–6.

    Article  CAS  PubMed  Google Scholar 

  28. Nagasaki T, Inaba M, Kumeda Y, Hiura Y, Shirakawa K, Yamada S, et al. Increased pulse wave velocity in subclinical hypothyroidism. J Clin Endocrinol Metab. 2006;91(1):154–8.

    Article  CAS  PubMed  Google Scholar 

  29. Nagasaki T, Inaba M, Yamada S, Kumeda Y, Hiura Y, Nishizawa Y. Changes in brachial-ankle pulse wave velocity in subclinical hypothyroidism during normalization of thyroid function. Biomed Pharmacother. 2007;61(8):482–7.

    Article  PubMed  Google Scholar 

  30. Nagasaki T, Inaba M, Yamada S, Shirakawa K, Nagata Y, Kumeda Y, et al. Decrease of brachial-ankle pulse wave velocity in female subclinical hypothyroid patients during normalization of thyroid function: a double-blind, placebo-controlled study. Eur J Endocrinol. 2009;160(3):409–15.

    Article  CAS  PubMed  Google Scholar 

  31. Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation. 2005;111(3):363–8.

    Article  PubMed  Google Scholar 

  32. Lekakis J, Papamichael C, Alevizaki M, Piperingos G, Marafelia P, Mantzos J, et al. Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid. 1997;7(3):411–4.

    Article  CAS  PubMed  Google Scholar 

  33. Razvi S, Ingoe L, Keeka G, Oates C, McMillan C, Weaver JU. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. J Clin Endocrinol Metab. 2007;92(5):1715–23.

    Article  CAS  PubMed  Google Scholar 

  34. Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, et al. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab. 2003;88(8):3731–7.

    Article  CAS  PubMed  Google Scholar 

  35. Marazuela M, Sanchez-Madrid F, Acevedo A, Larranaga E, de Landazuri MO. Expression of vascular adhesion molecules on human endothelia in autoimmune thyroid disorders. Clin Exp Immunol. 1995;102(2):328–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, et al. Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis. J Clin Endocrinol Metab. 2006;91(12):5076–82.

    Article  CAS  PubMed  Google Scholar 

  37. Kvetny J, Heldgaard PE, Bladbjerg EM, Gram J. Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin Endocrinol. 2004;61(2):232–8.

    Article  CAS  Google Scholar 

  38. Turemen EE, Cetinarslan B, Sahin T, Canturk Z, Tarkun I. Endothelial dysfunction and low grade chronic inflammation in subclinical hypothyroidism due to autoimmune thyroiditis. Endocr J. 2011;58(5):349–54.

    Article  CAS  PubMed  Google Scholar 

  39. Cikim AS, Oflaz H, Ozbey N, Cikim K, Umman S, Meric M, et al. Evaluation of endothelial function in subclinical hypothyroidism and subclinical hyperthyroidism. Thyroid. 2004;14(8):605–9.

    Article  PubMed  Google Scholar 

  40. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med. 2000;132(4):270–8.

    Article  CAS  PubMed  Google Scholar 

  41. Suarez J, Wang H, Scott BT, Ling H, Makino A, Swanson E, et al. In vivo selective expression of thyroid hormone receptor alpha1 in endothelial cells attenuates myocardial injury in experimental myocardial infarction in mice. Am J Physiol Regul Integr Comp Physiol. 2014;307(3):R340–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Carrillo-Sepulveda MA, Ceravolo GS, Fortes ZB, Carvalho MH, Tostes RC, Laurindo FR, et al. Thyroid hormone stimulates NO production via activation of the PI3K/Akt pathway in vascular myocytes. Cardiovasc Res. 2010;85(3):560–70.

    Article  CAS  PubMed  Google Scholar 

  43. Suarez J. Thyroid hormone receptor-beta promotes angiogenesis stimulating ERK phosphorylation. FASEB J. 2010;24(1).

    Google Scholar 

  44. Cheng SY, Leonard JL, Davis PJ. Molecular aspects of thyroid hormone actions. Endocr Rev. 2010;31(2):139–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Tomanek RJ, Doty MK, Sandra A. Early coronary angiogenesis in response to thyroxine: growth characteristics and upregulation of basic fibroblast growth factor. Circ Res. 1998;82(5):587–93.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Watford General Hospital, Watford, UK

    Avais Jabbar

  2. Institute of Clinical and Translational Medicine, Newcastle University/Queen Elizabeth Hospital, Newcastle upon Tyne, UK

    Salman Razvi

Authors
  1. Avais Jabbar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Salman Razvi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Salman Razvi .

Editor information

Editors and Affiliations

  1. Institute of Clinical Physiology (IFC) National Research Council (CNR), Pisa, Italy

    Giorgio Iervasi

  2. Institute of Clinical Physiology (IFC) National Research Council (CNR), Pisa, Italy

    Alessandro Pingitore

  3. NYITCOM College of Osteopathic Medicine Biomedical Sciences Department, Old Westbury, NY, USA

    A.Martin Gerdes

  4. Institute of Clinical and Translational Medicine, Newcastle University/Queen Elizabeth Hospital, Newcastle upon Tyne, UK

    Salman Razvi

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Jabbar, A., Razvi, S. (2020). Blood Pressure in Thyroid Dysfunction. In: Iervasi, G., Pingitore, A., Gerdes, A., Razvi, S. (eds) Thyroid and Heart . Springer, Cham. https://doi.org/10.1007/978-3-030-36871-5_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-36871-5_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-36870-8

  • Online ISBN: 978-3-030-36871-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation